研究MAPA-VIP对控制过敏喘病理生理学的影响
1Department of Respiratory and Critical Care Medicine, Affiliated Hospital of Northwest University, Xi'an No. 3 Hospital, Xi'an, China.
Postepy dermatologii i alergologii
|September 11, 2023
概括
一种新的药物输送系统,使用吸血性肠 (VIP) 和α-纳米颗粒有效治疗小鼠喘. 这种VIP-MapA-α-alumina系统减少了炎症和粘液的产生,为喘提供了有前途的治疗方法.
科学领域:
- 肺部医学 肺部医学
- 纳米技术纳米技术
- 免疫学 免疫学 免疫学
背景情况:
- 喘病原发生涉及免疫细胞和信号通路.
- 血管活性肠 (VIP) 显示出免疫调节作用.
- 阿尔法纳米颗粒具有治疗应用的潜力.
研究的目的:
- 评估一种用于喘治疗的新型药物输送系统.
- 在喘小鼠模型中研究VIP-MapA-α-alumina的疗效.
- 评估输送系统的免疫调节和抗炎作用.
主要方法:
- 向喘小鼠使用VIP-MapA-α-alumina.
- 测量乙氨基基基的百分比,IgE,IL-4,IL-5,IL-13的水平.
- 评估GATA3和MUC5AC基因表达,ROS水平,以及肺部组织病理学.
主要成果:
- 治疗VIP-MapA-α-alumina显著降低了乙氨基酸百分比,IgE,IL-4,IL-5,IL-13和ROS水平.
- 观察到GATA3和MUC5AC基因的表达减少.
- 组织病理学改善包括降低杯状细胞增生,粘液过度产生和炎症.
结论:
- 这种VIP-MapA-α-alumina输送系统有效地针对肺部进行喘治疗.
- MapA促进了VIP透到粘液和支气管细胞中,增强了治疗效果.
- 该系统为喘治疗提供了强烈的,长效的治疗效果.
相关概念视频
Asthma: Pathogenesis and Management
439
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
439
Asthma-II: Pathophysiology and Classification
2.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.7K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
332
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
332
Antiasthma Drugs: Leukotriene Modifiers
343
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
343
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Asthma-I: Introduction
2.7K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.7K


